132 related articles for article (PubMed ID: 29101390)
21. Conditional ERK3 overexpression cooperates with PTEN deletion to promote lung adenocarcinoma formation in mice.
Vallabhaneni S; Liu J; Morel M; Wang J; DeMayo FJ; Long W
Mol Oncol; 2022 Mar; 16(5):1184-1199. PubMed ID: 34719109
[TBL] [Abstract][Full Text] [Related]
22. Deubiquitinating Enzyme USP20 Regulates Extracellular Signal-Regulated Kinase 3 Stability and Biological Activity.
Mathien S; Déléris P; Soulez M; Voisin L; Meloche S
Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28167606
[TBL] [Abstract][Full Text] [Related]
23. Scaffolding by ERK3 regulates MK5 in development.
Schumacher S; Laass K; Kant S; Shi Y; Visel A; Gruber AD; Kotlyarov A; Gaestel M
EMBO J; 2004 Dec; 23(24):4770-9. PubMed ID: 15538386
[TBL] [Abstract][Full Text] [Related]
24. Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4.
Aberg E; Perander M; Johansen B; Julien C; Meloche S; Keyse SM; Seternes OM
J Biol Chem; 2006 Nov; 281(46):35499-510. PubMed ID: 16971392
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5.
Kant S; Schumacher S; Singh MK; Kispert A; Kotlyarov A; Gaestel M
J Biol Chem; 2006 Nov; 281(46):35511-9. PubMed ID: 16973613
[TBL] [Abstract][Full Text] [Related]
26. Regulation of ERK3/MAPK6 expression by BRAF.
Hoeflich KP; Eby MT; Forrest WF; Gray DC; Tien JY; Stern HM; Murray LJ; Davis DP; Modrusan Z; Seshagiri S
Int J Oncol; 2006 Oct; 29(4):839-49. PubMed ID: 16964379
[TBL] [Abstract][Full Text] [Related]
27. C-terminal domain phosphorylation of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis.
Tanguay PL; Rodier G; Meloche S
Biochem J; 2010 Apr; 428(1):103-11. PubMed ID: 20236090
[TBL] [Abstract][Full Text] [Related]
28. Distribution of ERK1/2 and ERK3 during normal rat fetal lung development.
Kling DE; Brandon KL; Sollinger CA; Cavicchio AJ; Ge Q; Kinane TB; Donahoe PK; Schnitzer JJ
Anat Embryol (Berl); 2006 Mar; 211(2):139-53. PubMed ID: 16374608
[TBL] [Abstract][Full Text] [Related]
29. Analysis of ERK3 intracellular localization: dynamic distribution during mitosis and apoptosis.
Aredia F; Malatesta M; Veneroni P; Bottone MG
Eur J Histochem; 2015 Dec; 59(4):2571. PubMed ID: 26708186
[TBL] [Abstract][Full Text] [Related]
30. The non-classical MAP kinase ERK3 controls T cell activation.
Marquis M; Boulet S; Mathien S; Rousseau J; Thébault P; Daudelin JF; Rooney J; Turgeon B; Beauchamp C; Meloche S; Labrecque N
PLoS One; 2014; 9(1):e86681. PubMed ID: 24475167
[TBL] [Abstract][Full Text] [Related]
31. Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3.
Schröder M; Filippakopoulos P; Schwalm MP; Ferrer CA; Drewry DH; Knapp S; Chaikuad A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114754
[TBL] [Abstract][Full Text] [Related]
32. The atypical mitogen-activated protein kinase ERK3 is essential for establishment of epithelial architecture.
Takahashi C; Miyatake K; Kusakabe M; Nishida E
J Biol Chem; 2018 Jun; 293(22):8342-8361. PubMed ID: 29674317
[TBL] [Abstract][Full Text] [Related]
33. ERK3/MAPK6 controls IL-8 production and chemotaxis.
Bogucka K; Pompaiah M; Marini F; Binder H; Harms G; Kaulich M; Klein M; Michel C; Radsak MP; Rosigkeit S; Grimminger P; Schild H; Rajalingam K
Elife; 2020 Apr; 9():. PubMed ID: 32314963
[TBL] [Abstract][Full Text] [Related]
34. The atypical MAPK ERK3 controls positive selection of thymocytes.
Sirois J; Daudelin JF; Boulet S; Marquis M; Meloche S; Labrecque N
Immunology; 2015 May; 145(1):161-9. PubMed ID: 25521218
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of mitogen-activated protein kinases in human colon cancers.
Wang Q; Ding Q; Dong Z; Ehlers RA; Evers BM
Anticancer Res; 2000; 20(1A):75-83. PubMed ID: 10769637
[TBL] [Abstract][Full Text] [Related]
36. Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality.
Klinger S; Turgeon B; Lévesque K; Wood GA; Aagaard-Tillery KM; Meloche S
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16710-5. PubMed ID: 19805361
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth.
Jin Y; Pan Y; Zheng S; Liu Y; Xu J; Peng Y; Zhang Z; Wang Y; Xiong Y; Xu L; Mu K; Chen S; Zheng F; Yuan Y; Fu J
Oncogene; 2022 Mar; 41(12):1752-1766. PubMed ID: 35124697
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning, isolation and characterisation of ERK3 gene from chewing-tobacco induced oral squamous cell carcinoma.
Rai R; Mahale A; Saranath D
Oral Oncol; 2004 Aug; 40(7):705-12. PubMed ID: 15172640
[TBL] [Abstract][Full Text] [Related]
39. A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions.
Niu Y; Roy F; Saltel F; Andrieu-Soler C; Dong W; Chantegrel AL; Accardi R; Thépot A; Foiselle N; Tommasino M; Jurdic P; Sylla BS
Mol Cell Biol; 2006 Jun; 26(11):4288-301. PubMed ID: 16705178
[TBL] [Abstract][Full Text] [Related]
40. ERK3 and DGKζ interact to modulate cell motility in lung cancer cells.
Myers AK; Morel M; Gee SH; Hoffmann KA; Long W
Front Cell Dev Biol; 2023; 11():1192221. PubMed ID: 37287450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
